Capital Structure Analysis - Bangladesh (Rezwana Nasreen & M. Shahryar Faiz)

ACI Pharmaceuticals Limited
Income Statement
Sales
COGS (excluding Depr)
Gross Profit
Operating Expenses (excluding Depr)
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
Profit Before Tax & WPPF
WPPF
Profit Before Tax
Income Tax
Deferred Tax
Minority Interest & Associate Undertakings
Profit After Tax
EPS
Balance Sheet
Current Assets
Cash & Cash Equivalent
Advance, Deposits & Prepayments
Accounts Receivables
Inventories
Short-term Investment
Total Current Assets
Non-Current Assets
Fixed Asset
Plant, Property & Equipment
Less: Accumulated Depreciation
Net PP&E
Capital Work-in-Progress
Long-term Investment
Other Non-Current Assets
Intangible Assets
Total Non-Current Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses (provision for taxation)
Other Payables (other cr. + inter co. lia.)
Short-term Borrowings(overdraft & term loan)
Current Portion of Long-term Debt
Total Current Liabilities
Non-Current Liabilities
Long-term Borrowings
Other Long-term Liabilities
Total Non-Current Liabilities
Shareholders' Equity
Issued Share Capital
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
Total Shareholders' Equity
Total Liabilities & Shareholders' Equity
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Book Value Per Share
Dividend Per Share
Return On Equity
Dividend Payout Ratio
Retention Ratio
No of Shares Outstanding (mn)
Year-End Market Price
Time Series Analysis

Capital Structure Analysis
Debt Ratio
(STD+LTD)/TA
Debt-Equity Ratio
Interest Coverage Ratio
Cashflow Coverage Ratio
Determinants Of Capital Structure

Tangibility
Uncertainty Of Operating Income
STDEV(EBIT)
Mean of EBIT
Growth Rate
Ownership Structure %
Sponsors
Govt.
Foreign
Institutions
Public
Sponsor % (Ownership Structure)
Free-Float % (Ownership Structure)
Basic Earning Power
Operating Profit Margin
Degree of Operating Leverage
Stability Of Sales
Operating Expense Ratio
BV-MV Ratio (Proxy For Distress)
LTD/E
EBIT/i
OCF/{i+(P/(1-T))}
PPE/TA
STDEV(EBIT)/Mean of EBIT
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
2004
2,557.77
1,817.39
740.38
517.41
222.97
23.01
42.04
242.00
93.16
148.84
7.44
141.40
38.50
13.37
2005
3,088.71
2,131.53
957.18
696.58
260.60
29.55
30.32
261.37
83.96
177.41
8.89
168.52
51.44
5.35
2006
2007
2008
figures are in million (except
3,515.86 4,917.30
5,958.85
2,339.97 3,250.71
4,017.43
1,175.89 1,666.59
1,941.42
852.95 1,203.49
1,292.43
322.94
463.10
648.99
31.52
31.60
32.10
35.34
142.15
835.79
326.76
573.65
1,452.68
81.55
119.08
251.97
245.21
454.57
1,200.71
12.26
22.72
21.05
232.95
431.85
1,179.66
97.59
124.51
97.71
(18.48)
(5.71)
9.24
2009
2010
the per share data)
7,228.28
7,915.40
4,862.55
5,094.56
2,365.73
2,820.84
1,686.72
1,886.15
679.01
934.69
32.50
33.50
697.08
86.24
1,343.59
987.43
212.74
136.84
1,130.85
850.59
23.84
42.52
1,107.01
808.07
117.41
213.84
0.59
2.61
89.53
111.73
153.84
313.05
1,072.71
989.01
591.62
#MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO?
58.02
150.64
427.76
705.92
1,342.34
56.70
183.15
593.71
703.56
1,537.12
43.05
206.14
769.16
736.67
1,755.02
57.19
385.42
1,586.86
1,091.39
3,120.86
211.92
418.07
1,680.81
1,838.73
839.59
4,989.12
717.86
651.24
2,403.30
1,596.52
154.44
637.29
3,293.29
1,716.07
5,368.92
5,801.09
740.96
946.14
265.31
680.83
60.13
295.38
756.76
1,073.39
329.92
743.47
13.29
380.78
731.32
1,094.19
399.87
694.32
37.00
428.81
1,073.30
1,327.15
467.72
859.43
213.87
536.62
1,255.67
1,669.95
549.37
1,120.58
135.09
670.26
1,281.89
1,829.79
654.02
1,175.77
106.12
1,091.39
2,435.11
1,813.31
57.07
1,756.24
678.87
1,447.69
1,036.34
1,137.54
1,160.13
1,609.92
1,925.93
2,373.28
2.33
3,885.13
2,378.68
2,674.66
2,915.15
4,730.78
6,915.05
7,742.20
9,686.22
48.70
48.70
303.20
747.89
12.43
1,160.92
76.03
90.50
543.19
795.60
18.86
1,524.18
79.63
153.44
668.62
825.24
14.07
1,741.00
132.27
277.96
1,236.98
1,413.58
72.72
3,133.51
325.56
236.55
1,100.84
2,548.74
189.04
4,400.73
377.16
353.96
1,210.10
2,175.73
63.12
4,180.07
211.83
348.97
735.18
2,494.84
296.30
4,087.12
309.66
320.51
1,140.92
309.66
320.51
1,140.92
161.70
250.02
1,488.14
194.04
250.02
2,302.90
194.04
250.02
2,691.05
1.67
1.67
424.87
896.53
4,458.18
9,686.22
356.24
356.24
244.35
244.35
186.99
186.99
325.16
325.16
161.70
250.02
138.62
161.70
250.02
189.08
161.70
250.02
247.52
161.70
250.02
563.80
3.79
75.59
231.80
861.52
2.78
72.76
229.79
906.13
1.67
97.02
229.23
987.16
1.67
294.92
1,272.11
303.13
2,204.66
1.67
192.69
300.30
3,241.62
2,378.68
2,674.66
2,915.15
4,730.78
6,915.05
7,742.20
65.00
80.00
44.00
410.00
264.00
131.00
556.00
260.20
267.69
123.04
(483.37)
(833.26)
514.10
910.12
0.37
0.34
0.34
0.28
0.09
0.11
0.27
53.28
56.04
61.05
78.67
136.36
164.55
226.30
4.25
4.50
6.00
8.50
12.00
10.50
12.00
16.17
16.17
16.17
16.17
16.17
19.70
19.70
94.40
69.60
70.20
185.00
521.30
446.90
372.60

2.31
2.38
1.20
(2.20)
(1.81)
1.81
1.68

0.16
0.43
0.75
0.43
0.19
0.22
44.41
164.70
591.80
479.13
243.31
251.84
276.71
387.26
784.36
1,123.31
1,261.23
1,165.51
0.06
36.85
36.84
36.81
36.81
36.76
36.76
27.43
31.31
38.74
37.48
37.48
31.18
31.18
72.51
31.84
24.42
25.71
25.71
32.06
32.06
0.06
36.85
36.84
36.81
36.81
36.76
36.76
99.94
63.15
63.16
63.19
63.19
63.24
63.24
0.09
0.08
0.09
0.12
0.24
0.19
0.12
#DIV/0! #MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO?
479.98
956.58 1,225.91
1,157.36
992.61
485.87
0.56
0.81
0.87
0.43
0.26
0.37
0.61
Average
5,291.82
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
Ambee Pharmaceuticals Ltd

Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses
Other Payables
Short-term Borrowings
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio

Debt Ratio
Debt-Equity Ratio
(STD+LTD)/TA
LTD/E


Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
EBIT/i
OCF/{i+(P/(1-T))}
PPE/TA
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
2004
198.45
101.44
97.01
76.98
20.03
2.99
2005
173.67
89.41
84.26
66.28
17.98
3.14
2006
figures are
222.32
102.84
119.48
94.25
25.23
2.97
2007
2008
2009
2010
in million (except the per share data)
347.24
240.73
253.77
268.49
195.52
100.40
111.21
122.08
151.72
140.33
142.56
146.41
122.96
117.02
117.04
121.11
28.76
23.31
25.52
25.30
4.95
4.85
4.73
4.24
17.04
8.14
8.90
0.44
8.46
2.54
14.84
9.37
5.47
0.27
5.20
1.56
22.26
11.33
10.93
0.55
10.38
5.38
23.81
12.17
11.64
0.58
11.06
3.32
18.46
10.18
8.28
0.41
7.87
1.52
20.79
11.41
9.38
0.47
8.91
2.01
21.06
10.45
10.61
0.53
10.08
2.71
5.92
2.96
3.64
1.82
5.00
2.50
7.74
3.87
6.35
3.18
6.90
3.45
7.37
3.69
0.42
31.83
51.11
48.95
0.94
32.90
89.25
36.82
2.93
35.52
53.09
125.41
0.43
34.16
88.29
105.26
5.22
39.50
38.48
135.90
6.15
57.81
35.39
132.93
2.06
65.12
44.59
117.21
132.31
159.91
216.95
228.14
219.10
232.28
228.98
49.02
98.16
49.14
49.02
47.29
99.57
52.28
47.29
58.02
113.28
55.26
58.02
59.15
119.35
60.20
59.15
59.48
124.53
65.05
59.48
56.66
126.44
69.78
56.66
57.41
131.43
74.02
57.41
49.02
47.29
58.02
59.15
59.48
56.66
57.41
181.33
207.20
274.97
287.29
278.58
288.94
286.39
7.35
7.85
11.15
11.27
10.60
8.82
9.96
Average
257.81
12.23
9.23
96.74
14.79
10.79
119.37
13.18
5.62
199.47
15.08
8.76
203.88
14.88
13.36
193.22
18.25
21.03
193.42
23.73
28.95
174.96
125.55
152.80
229.42
238.99
232.06
241.52
237.60
20.00
20.00
20.00
20.00
20.00
20.00
20.00
30.65
29.27
20.42
23.17
21.39
22.29
23.66
5.13
5.13
5.13
5.13
5.13
5.13
5.13
55.78
54.40
45.55
48.30
46.52
47.42
48.79
181.33
207.20
274.97
287.29
278.58
288.94
286.39
4.16
8.16
0.30
27.89
2.50
0.11
0.84
0.16
2.00
65.64
0.53
-
1.41
6.41
0.30
27.20
2.50
0.07
1.37
(0.37)
2.00
49.80
0.58
-
13.69
27.55
0.52
22.78
2.50
0.11
1.00
2.00
43.40
6.07
5.06
0.30
24.15
3.00
0.16
0.78
0.22
2.00
53.70
6.51
25.07
0.19
23.26
3.00
0.14
0.94
0.06
2.00
129.20
0.70
24.23
0.23
23.71
3.00
0.15
0.87
0.13
2.00
209.40
4.99
25.51
0.27
24.40
3.00
0.15
0.81
0.19
2.00
497.20
0.73
-
0.71
-
0.69
-
0.67
-
0.61
-
0.65
-
2.09
1.00
1.58
0.68
0.27
0.23
0.21
3.81
18.05
(0.03)
0.02
64.72%
0.00%
8.95%
23.11%
3.22%
64.72%
0.35
0.09
0.09
0.40
0.42
64.72%
0.00%
8.95%
21.71%
4.62%
64.72%
0.35
0.07
0.09
1.03
24.33
0.40
0.55
1.96
2.43
1.96
0.42
1.81
2.46
1.82
2.12
2.02
2.44
1.89
1.65
0.21
0.24
4.79
20.30
-
0.21
0.13
2.75
21.51
0.04
0.21
0.13
2.68
21.02
0.01
0.20
0.07
1.43
20.10
0.02
0.20
0.01
0.19
20.93
0.03
0.22
0.13
2.61
20.32
###
64.72%
0.00%
8.95%
23.64%
2.69%
64.72%
0.35
0.08
0.10
1.78
89.53
0.44
0.52
64.72%
0%
8.95%
23.34%
2.99%
64.72%
35.28%
0.08
0.07
0.12
67.44
0.37
0.45
64.72%
0%
8.95%
15.85%
10.48%
64.72%
35.28%
0.07
0.08
0.73
58.10
0.51
0.18
65%
0%
8.95%
24.17%
2.11%
64.77%
35.23%
0.07
0.08
2.33
13.89
0.48
0.11
64%
0%
8.95%
22.12%
4.66%
64.27%
35.73%
0.07
0.08
0.22
10.41
0.47
0.05
0.35
0.08
0.08
1.04
43.95
0.44
0.33
Beximco Pharmaceuticals
Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses
Other Payables
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio

Debt Ratio
(STD+LTD)/TA
Debt-Equity Ratio

Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
LTD/E
EBIT/i
OCF/{i+(P/(1-T))}
PPE/TA
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
2004
2005
2006
2007
2008
2009
2010
figures are in million (except the per share data)
3,702.32
3,597.02
4,010.17
4,868.25
6,490.85
1,829.35
1,829.02
1,871.88
2,311.54
2,924.75
1,872.97
1,768.00
2,138.29
2,556.71
3,566.10
965.07
955.84
992.31
1,269.29
1,496.18
907.90
812.16
1,145.98
1,287.42
2,069.92
161.37
157.38
147.18
286.15
434.13
56.20
19.63
0.69
198.99
456.01
802.73
674.41
999.49
1,200.26
2,091.80
253.32
254.74
249.65
289.43
662.18
549.41
419.67
749.84
910.83
1,429.62
26.16
19.98
35.71
43.37
68.08
523.25
399.69
714.13
867.46
1,361.54
35.40
57.66
173.72
71.08
17.18
(11.10)
(4.94)
242.73
238.80
2,402.70
1,286.94
1,115.76
458.03
657.73
101.39
3.85
560.19
190.58
369.61
15.93
353.68
28.47
(4.18)
3,327.02
1,661.04
1,665.98
813.97
852.01
127.66
7.23
731.58
221.95
509.63
24.27
485.36
46.17
(50.06)
329.39
#MACRO?
489.25
#MACRO?
470.67
#MACRO?
353.13
#MACRO?
545.35
#MACRO?
624.73
#MACRO?
1,051.66
#MACRO?
8.00
468.68
600.00
1,394.80
2,471.48
428.60
603.80
779.80
1,683.70
3,495.90
581.10
591.60
430.24
1,754.44
3,357.38
85.70
685.92
499.68
1,652.48
2,923.78
73.65
544.51
503.92
1,739.82
2,861.90
1,058.43
699.20
694.11
1,964.98
2,500.00
6,916.72
1,471.45
779.13
821.36
2,260.33
859.40
6,191.67
6,149.83
6,149.83
7,412.47
7,412.47
8,513.14
8,513.14
8,992.94
8,992.94
11,921.07
11,921.07
12,966.59
12,966.59
15,123.31
15,123.31
6,149.83
7,412.47
8,513.14
8,992.94
11,921.07
12,966.59
15,123.31
37.16
37.16
41.98
36.70
36.70
2.88
6.30
6,186.99
7,449.63
8,555.12
9,029.64
11,957.77
5.73
12,975.20
51.13
15,180.74
8,658.47
10,945.53
11,912.50
11,953.42
14,819.67
19,891.92
21,372.41
206.45
46.72
28.01
1,121.91
298.45
1,701.54
216.66
101.86
55.26
1,062.01
1,066.03
2,501.82
365.26
117.94
29.29
1,302.82
712.12
2,527.43
271.80
60.10
44.90
907.58
343.60
1,627.98
263.18
81.78
147.25
1,461.67
648.17
2,602.05
409.90
79.09
72.31
1,451.33
308.82
2,321.45
432.32
90.51
1.51
1,639.96
348.86
2,513.16
1,919.35
201.60
2,120.95
1,387.46
235.27
1,622.73
1,159.41
275.76
1,435.17
1,776.45
298.05
2,074.50
1,446.60
320.83
1,767.43
1,924.93
4,759.84
6,684.77
1,902.15
983.01
2,885.16
559.76
1,489.75
2,341.10
959.22
1,489.75
2,693.30
1,040.97
1,489.75
3,039.77
1,145.10
1,489.75
3,189.18
1,259.58
1,489.75
4,005.11
1,511.49
1,489.75
4,282.51
2,098.07
5,269.47
5,087.31
445.36
4,835.97
709.50
969.18
6,820.94
689.78
1,689.64
7,949.91
737.30
1,689.64
8,250.97
294.95
1,689.64
1,711.17
10,450.20
294.95
1,689.64
1,617.36
10,885.70
294.95
1,689.64
1,534.65
15,974.09
8,658.46
10,945.50
11,912.51
11,953.45
14,819.68
19,891.92
21,372.41
(0)
(0)
(0)
289.07
82.95
0.07
86.43
5.00
#MACRO?
#MACRO?
#MACRO?
55.95
85.74
904.86
311.63
(0.01)
88.67
15.00
#MACRO?
#MACRO?
#MACRO?
76.93
43.69
1,083.03
1,079.53
0.10
78.88
5.00
#MACRO?
#MACRO?
#MACRO?
100.78
53.71
459.00
340.47
0.12
65.43
5.00
#MACRO?
#MACRO?
#MACRO?
126.10
53.54
3,085.51
880.73
0.24
69.18
1.00
#MACRO?
#MACRO?
#MACRO?
151.06
167.68
1,331.67
520.93
0.28
62.55
#MACRO?
#MACRO?
#MACRO?
174.02
155.81
2,595.10
1,352.21
0.23
78.50
#MACRO?
#MACRO?
#MACRO?
203.48
134.00
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0.16
#MACRO?
#MACRO?
0.24
#MACRO?
#MACRO?
1.03
#MACRO?
#MACRO?
0.53
#MACRO?
#MACRO?
0.80
#MACRO?
#MACRO?
0.73
#MACRO?
#MACRO?
1.21
#MACRO?
#MACRO?
0.18
124.67
698.17
#MACRO?
#MACRO?
0.09
64.29
736.24
#MACRO?
#MACRO?
0.20
163.74
825.54
#MACRO?
#MACRO?
0.28
265.36
958.05
#MACRO?
#MACRO?
0.41
581.42
1,430.52
#MACRO?
#MACRO?
0.38
630.41
1,646.03
#MACRO?
22.38
21.76
14.79
41.07
22.38
77.62
#MACRO?
0.22
#MACRO?
668.86
#MACRO?
2.03
20.63
29.78
13.68
35.91
20.63
79.37
#MACRO?
0.22
#MACRO?
193.58
#MACRO?
1.47
20.63
33.45
11.25
34.67
20.63
79.37
#MACRO?
0.19
#MACRO?
214.69
#MACRO?
1.22
20.63
28.49
10.23
40.65
20.63
79.37
#MACRO?
0.25
#MACRO?
648.46
#MACRO?
0.41
10.91
27.66
10.46
50.97
10.91
89.09
#MACRO?
0.25
#MACRO?
1,259.82
#MACRO?
0.40
12.97
23.02
11.21
52.80
12.97
87.03
#MACRO?
0.32
#MACRO?
1,147.35
#MACRO?
0.59
#MACRO?
26.94
1.36
21.57
50.13
26.94
73.06
#MACRO?
0.23
#DIV/0!
#MACRO?
1.01
Average
14,221.99
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
Glaxo Smithkline Bangladesh Limited

Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income /Finance income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Other Non-Current Assets (Deferred tax asset)
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses
Other Payables (Current tax liabilities)
Current Portion of Long-term Debt (Obligation under finance Lease)
Long-term Borrowings (Obligation under finance lease)
Other Long-term Liabilities (Retirement benefit obligations/Deferred tax liability)
Share Premium
Retained Earnings
General Reserve
Capital Reserve
Others
Revaluation Surplus
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio

Debt Ratio
Debt-Equity Ratio

Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
2004
1,272.60
922.12
350.48
225.49
125.00
37.08
119.33
207.247
207.25
207.25
23.73
-
2005
1,342.65
1,015.65
326.99
215.71
111.29
39.86
6.81
78.23
78.23
78.23
29.39
-
2006
2007
2008
figures are in million (except the per s
1,439.34
1,589.09
1,888.11
1,127.24
1,214.38
1,381.64
312.10
374.71
506.47
280.15
255.93
249.29
31.95
118.79
257.18
46.20
49.05
48.99
9.25
12.00
4.84
(5.00)
81.73
213.04
3.83
4.58
8.43
(8.83)
77.15
204.61
(8.83)
77.15
204.61
8.29
32.07
61.66
-
183.52
48.85
(17.12)
45.08
142.95
#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?
219.13
126.58
474.75
820.46
85.87
166.02
530.18
782.07
5.33
143.46
527.13
675.91
21.28
284.84
425.38
731.50
1.94
420.32
596.21
1,018.46
278.30
278.30
290.66
290.66
303.96
303.96
318.11
318.11
326.47
326.47
278.30
290.66
303.96
318.11
326.47
5.06
283.36
0.09
290.75
31.10
335.05
18.86
336.97
17.42
343.89
1,103.83
1,072.83
1,010.96
1,068.47
1,362.35
eferred tax liability)
157.09
20.17
1.68
178.95
157.45
8.04
108.10
(8.87)
2.68
101.91
174.27
(19.96)
328.50
13.17
3.31
157.62
2.34
344.00
7.93
79.82
87.75
7.79
77.47
85.26
5.11
137.56
142.67
3.64
107.83
111.47
1.30
104.84
106.14
120.47
651.85
5.00
59.82
837.13
120.47
634.44
5.00
59.82
819.72
120.47
581.18
5.00
59.74
766.38
120.47
614.17
5.00
59.74
799.38
120.47
727.00
5.00
59.74
912.21
1,103.83
1,072.83
1,010.96
1,068.47
1,362.35
2.36
167.85
60.17
121.87
66.20
76.36
58.49
15.66
47.01
14.70
85.59
66.14
0.11
0.38
(0.94)
0.42
0.30
69.49
68.05
63.62
66.36
75.72
5.00
3.00
1.00
2.50
6.00
12.05
12.05
12.05
12.05
12.05
143.16
134.82
135.50
192.98
330.10
(STD+LTD)/TA
LTD/E
EBIT/i
OCF/{i+(P/(1-T))}

#DIV/0!
#DIV/0! #MACRO? #MACRO? #MACRO?
8.24
12.43
2.82
8.35
5.62
PPE/TA

1.14
0.95
1.14
0.74
106.94
49.09
109.77
181.06
93.49
51.66
96.59
244.81
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
81.98
81.98
81.98
81.98
81.98
17.17
17.75
17.63
17.23
16.41
0.85
0.27
0.39
0.79
1.61
81.98
81.98
81.98
81.98
81.98
18.02
18.02
18.02
18.02
18.02
0.16
0.06
(0.00)
0.05
0.11
#DIV/0! #MACRO? #MACRO? #MACRO? #MACRO?
83.73
124.17
228.48
756.85
0.49
0.50
0.47
0.34
0.23
2009
2010
n (except the per share data)
3,023.67
3,632.10
2,042.76
2,351.10
980.92
1,281.00
504.37
695.85
476.54
585.15
51.62
53.69
14.72
22.12
439.65
553.58
0.83
0.82
438.82
552.76
438.82
552.76
115.04
142.58
-
Average
323.79
410.18
#MACRO? #MACRO?
314.30
409.46
610.53
1,334.28
666.04
462.90
695.23
1,824.18
348.82
348.82
368.10
368.10
348.82
368.10
18.40
367.22
22.01
390.11
1,701.50
2,214.29
1,362.03
361.46
66.52
1.17
429.16
632.88
69.22
1.30
703.39
4.94
103.69
108.63
3.64
126.10
129.74
120.47
978.51
5.00
59.74
1,163.72
120.47
1,196.04
5.00
59.65
1,381.15
1,701.50
2,214.28
75.48
75.63
453.92
615.22
0.26
0.26
96.60
114.65
16.00
20.00
#MACRO? #MACRO?
#MACRO? #MACRO?
#MACRO? #MACRO?
12.05
12.05
725.22
1,129.44
#MACRO? #MACRO? #MACRO?

#MACRO? #MACRO?
#DIV/0!
187.51
239.46 #MACRO?

0.43
0.16 #MACRO?
173.35
80.56 #MACRO?
402.09
496.62 #MACRO?
81.98
81.98
13.57
13.96
4.45
4.06
81.98
81.98
18.02
18.02 #MACRO?
0.15
0.15 #MACRO?
#MACRO? #MACRO?
#DIV/0!
885.17
430.22 #MACRO?
0.13
0.10 #MACRO?
IBN SINA Pharmaceuticals IND LTD

Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
2004
447.95
288.33
159.62
109.54
50.08
10.71
3.42
42.79
1.57
41.22
1.96
39.26
10.60
28.66
###
22.83
27.09
0.20
48.54
98.66
146.29
228.20
81.91
146.29
15.35
161.64
260.30
68.94
Accrued Expenses
Other Payables
10.35
27.16
106.45
7.74
7.74
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
4.39
146.11
260.30
90.00
51.72
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio
29.96
33.81
0.27
162.34
21.00
###
###
###
0.90
777.75

Debt Ratio
Debt-Equity Ratio
(STD+LTD)/TA
LTD/E
###
###


Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
EBIT/i
OCF/{i+(P/(1-T))}
###
21.54
PPE/TA
###
ROE*RR
###
50.00
-
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
3.68
43.83
50.00
47.51
###
0.10
#DIV/0!
###
0.21
2005
534.74
334.89
199.85
143.77
56.08
12.38
3.95
47.65
0.53
47.12
2.24
44.88
12.12
32.76
###
2006
2007
2008
2009
2010
577.43
791.68
1,052.31
1,277.87
1,605.17
356.57
493.15
637.65
769.43
964.49
220.86
298.53
414.66
508.44
640.68
181.46
247.67
343.73
431.55
533.12
39.40
50.86
70.93
76.89
107.56
13.69
15.99
18.20
21.35
29.14
5.00
6.33
8.90
13.74
16.32
30.72
41.20
61.63
69.28
94.74
1.17
2.27
4.75
5.10
8.81
29.55
38.93
56.88
64.18
85.93
1.40
1.85
2.71
3.06
4.09
28.15
37.08
54.17
61.12
81.84
7.60
9.02
13.23
14.30
20.33
(2.34)
(2.41)
1.44
20.55
###
Average
28.06
43.28
49.23
60.07
### #MACRO? #MACRO? #MACRO?
20.35
40.40
0.19
51.55
112.49
27.70
47.50
1.44
52.14
128.78
34.04
57.22
0.18
58.47
149.91
81.10
78.40
0.60
60.04
220.14
76.49
85.47
0.86
62.23
79.11
95.83
1.40
66.40
225.05
242.74
159.92
254.21
94.29
159.92
184.71
292.69
107.98
184.71
218.55
342.52
123.97
218.55
257.91
257.91
332.85
494.84
161.99
332.85
330.22
520.58
190.36
330.22
18.30
22.73
29.53
35.61
44.73
1.46
52.64
0.02
178.22
207.44
248.08
293.52
379.04
382.88
290.71
336.22
397.99
513.66
604.09
625.62
31.56
15.06
14.84
14.23
19.21
51.46
257.91
432.66
16.88
55.26
27.04
22.74
67.94
61.26
19.71
69.20
112.32
16.98
56.96
169.59
6.89
264.65
22.94
59.90
186.61
19.78
308.44
54.30
78.51
55.39
16.94
256.60
130.74
167.00
216.07
7.60
12.94
12.94
27.83
32.49
60.32
39.94
40.31
80.25
48.73
51.54
100.27
7.60
90.00
90.00
90.00
90.00
90.00
108.00
65.58
67.22
74.59
94.28
121.02
156.34
4.39
4.39
4.39
4.39
4.39
4.39
159.97
161.61
168.98
188.67
215.41
268.73
290.71
336.21
397.99
513.64
604.10
625.60
(0)
(0)
26.01
50.56
0.27
177.74
21.00
###
###
###
0.90
584.75
38.48
22.74
0.27
179.57
21.00
###
###
###
0.90
639.50
49.83
57.68
94.63
25.71
18.09
41.16
68.57
141.62
0.24
0.20
0.19
0.27
187.76
209.63
199.45
248.82
23.00
7.50
7.50
10.00
0.90
0.90
1.08
1.08
786.75
995.75
1,552.50
1,615.75
###
###
###
###

###
###
###
95.58
###
19.44

7.97
3.08
2.31
4.44
###
###
###
0.22
8.72
40.39
###
###
0.21
8.55
39.86
###

0.35
0.25
0.23
0.22
15.72
14.51
17.33
18.00
44.52
57.37
75.22
82.01
###
###
###
###
###
50.00
-
50.00
-
50.00
-
3.68
43.83
50.00
47.51
###
0.09
###
65.98
###
0.30
4.06
45.94
50.00
50.00
###
0.05
###
137.69
###
0.28
48.33
-
48.33
-
48.33
-
4.06
8.81
8.81
8.81
45.94
42.86
42.86
42.86
50.00
48.33
48.33
48.33
50.00
51.67
51.67
51.67
###
###
0.05
0.06
0.05
0.06
###
### #MACRO? #MACRO? #MACRO? #DIV/0!
237.82
243.31
277.99
231.44
###
###
0.24
0.21
0.13
0.15
###
Renata Limited
Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses
Other Payables
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio

Debt Ratio
(STD+LTD)/TA
Debt-Equity Ratio

Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
LTD/E
EBIT/i
OCF/{i+(P/(1-T))}
PPE/TA
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
2004
1,470.13
787.73
682.40
421.60
260.80
22.40
10.29
248.69
38.33
210.36
10.42
199.94
59.32
3.50
2005
1,784.92
928.56
856.36
487.43
368.93
25.52
10.07
353.48
35.19
318.29
15.16
303.13
88.16
(1.35)
2006
2007
2008
2009
2010
2,165.60
2,729.92
3,203.20
4,102.59
5,424.44
1,076.76
1,414.66
1,570.80
1,874.66
2,462.96
1,088.84
1,315.26
1,632.40
2,227.93
2,961.48
588.57
708.02
841.92
1,112.44
1,363.12
500.27
607.24
790.48
1,115.49
1,598.36
30.29
48.59
68.84
95.57
159.84
20.70
15.53
13.52
4.27
2.36
490.68
574.18
735.16
1,024.19
1,440.88
43.96
60.95
88.96
100.44
117.74
446.72
513.23
646.20
923.75
1,323.14
21.27
24.45
30.77
43.97
63.00
425.45
488.78
615.43
879.78
1,260.14
98.23
121.82
176.77
219.66
235.56
6.86
8.88
42.69
137.12
216.32
320.36
358.08
438.66
660.12
#MACRO?
981.89
#MACRO?
72.58
30.47
103.54
404.93
611.52
99.17
35.45
142.01
421.55
698.18
116.23
62.53
187.39
677.31
1,043.46
95.79
71.48
200.48
707.04
1,074.79
142.79
84.02
322.50
1,008.28
1,557.59
170.26
86.37
340.07
1,133.43
1,730.13
210.01
117.24
465.36
1,350.08
2,142.69
555.26
544.58
672.86
532.97
868.56
824.40
1,235.89
927.83
1,737.70
1,135.90
2,306.50
1,569.54
3,151.87
2,787.87
544.58
10.68
4.15
559.41
532.97
139.89
4.15
677.01
824.40
44.16
6.47
875.03
927.83
308.06
15.66
1,251.55
1,135.90
601.80
22.74
1,760.44
1,569.54
736.96
26.90
2,333.40
2,787.87
364.00
163.55
3,315.42
1,170.93
1,375.19
1,918.49
2,326.34
3,318.03
4,063.53
5,458.11
14.37
42.16
78.40
240.93
375.86
27.84
69.96
108.82
192.43
399.05
53.61
76.68
166.78
371.85
668.92
42.16
106.38
235.80
361.48
745.82
127.28
140.06
242.43
823.16
1,332.93
32.51
180.59
431.46
794.42
1,438.98
33.35
230.08
489.78
1,129.41
1,882.62
78.78
110.48
189.26
65.89
116.30
182.19
33.83
135.32
169.15
22.45
160.32
182.77
10.55
186.76
197.31
0.62
234.36
234.98
291.26
291.26
55.79
304.84
206.11
39.06
605.80
66.94
460.08
220.05
46.86
793.93
80.33
781.48
218.57
1,080.38
96.40
1,081.64
219.72
1,397.76
115.68
1,446.27
225.80
1,787.75
144.60
1,983.51
261.44
2,389.55
180.75
2,788.62
314.81
3,284.18
1,170.92
1,375.17
1,918.45
2,326.35
3,317.99
4,063.51
5,458.06
(0)
124.73
153.18
234.46
425.52
580.67
165.58
211.46
69.19
433.15
222.41
0.31
0.29
0.25
0.27
0.29
1,085.89
1,185.97
1,344.89
1,208.29
1,236.35
50.00
50.00
50.00
50.00
50.00
0.56
0.67
0.80
1.16
1.45
3,079.93
2,701.13
3,098.49
6,242.41
7,787.51
642.57
818.47
0.25
1,322.01
60.00
#MACRO?
#MACRO?
#MACRO?
1.81
12,048.28
1,018.82
934.83
0.22
1,453.61
60.00
#MACRO?
#MACRO?
#MACRO?
2.26
12,941.03
#MACRO?
#MACRO?

4.32
6.01
1.57
7.11
2.50
#MACRO?
#MACRO?
8.15
#MACRO?
#MACRO?
7.94

0.33
0.24
0.21
0.29
121.36
111.43
124.27
228.02
364.28
472.78
600.01
777.84
#MACRO?
0.33
354.78
1,066.74
#MACRO?
#MACRO?
0.24
294.64
1,232.54
#MACRO?
51.00
51.00
25.00
25.33
15.00
14.97
9.00
8.70
51.00
51.00
49.00
49.00
0.17
0.20
0.23
0.21
0.23
#DIV/0! #MACRO? #MACRO? #MACRO? #MACRO?
348.25
475.46
519.47
697.27
0.35
0.44
0.43
0.19
0.16
51.00
25.33
13.55
10.12
51.00
49.00
#MACRO?
0.25
#MACRO?
1,117.30
#MACRO?
0.11
51.00
22.46
13.49
13.05
51.00
49.00
#MACRO?
0.27
#MACRO?
934.69
#MACRO?
0.11
Average
2,804.37
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
Square Pharmaceuticals
Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses
Other Payables
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio

Debt Ratio
(STD+LTD)/TA
Debt-Equity Ratio

Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
LTD/E
EBIT/i
OCF/{i+(P/(1-T))}
PPE/TA
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
2004
4,721.55
2,559.62
2,161.93
643.27
1,518.66
289.45
88.68
1,317.89
108.67
1,209.22
57.58
1,151.64
181.59
-
2005
5,332.05
2,892.92
2,439.13
797.45
1,641.68
303.95
357.40
1,695.12
106.45
1,588.67
75.65
1,513.02
257.17
-
2006
6,089.91
3,273.10
2,816.80
940.60
1,876.20
296.00
169.35
1,749.56
139.86
1,609.69
76.65
1,533.04
333.31
33.87
970.04
1,255.85
1,165.86
2007
2008
figures are in million
7,500.81
8,257.84
3,942.66
4,530.27
3,558.16
3,727.57
1,185.91
1,626.83
2,372.25
2,100.74
546.50
391.44
220.14
604.63
2,045.90
2,313.93
236.85
351.87
1,809.05
1,962.07
86.15
93.43
1,722.91
1,868.63
347.98
409.66
71.68
77.11
2009
(except the per share data)
9,820.80
5,043.65
4,777.15
1,581.31
3,195.84
827.40
665.52
3,033.96
397.14
2,636.82
125.56
2,511.26
592.64
28.56
1,303.24
#MACRO?
1,381.86
#MACRO?
1,890.05
#MACRO?
52.08
107.18
225.12
795.86
835.83
2,016.06
382.07
146.04
267.53
1,144.91
1,301.95
3,242.50
316.72
166.49
288.73
1,342.36
1,917.37
4,031.68
139.86
236.46
322.86
1,544.19
1,439.14
3,682.51
205.30
288.81
360.25
2,026.74
1,530.75
4,411.84
293.46
260.33
477.56
2,098.76
713.41
3,843.51
2,639.41
3,408.48
1,171.34
2,237.14
402.27
1,221.90
3,004.60
3,786.22
1,468.86
2,317.36
687.24
1,660.83
3,351.47
4,030.14
1,756.38
2,273.76
1,077.71
1,915.83
4,012.24
5,803.50
2,272.50
3,531.00
481.24
2,792.19
4,679.54
6,893.45
2,805.02
4,088.43
591.11
3,611.74
4,899.68
8,343.69
3,444.01
4,899.68
4,508.05
3,861.31
4,665.43
5,267.30
6,804.43
8,291.29
9,407.73
5,877.36
7,907.93
9,298.99
10,486.94
12,703.13
13,251.24
52.65
16.93
229.03
896.15
55.92
1,250.68
83.85
102.40
250.57
1,370.26
142.88
1,949.95
79.39
49.77
399.02
1,471.16
261.42
2,260.76
60.60
24.57
426.44
1,818.78
225.18
2,555.57
100.95
32.29
400.91
2,669.69
297.00
3,500.85
124.22
69.57
617.14
1,534.35
295.59
2,640.87
36.54
36.54
389.19
389.19
602.35
33.87
636.22
492.57
105.55
598.12
602.58
182.66
785.24
449.76
211.22
660.98
360.00
2,035.47
1,235.07
105.88
853.73
4,590.14
432.00
2,035.47
2,075.81
105.88
919.64
5,568.79
496.80
2,035.47
2,816.19
105.88
947.68
6,402.01
596.16
2,035.47
3,493.82
105.88
1,101.94
7,333.26
894.24
2,035.47
4,279.52
105.88
1,101.94
8,417.04
1,207.22
2,035.47
5,498.90
105.88
1,101.94
9,949.40
5,877.36
7,907.93
9,298.99
10,486.94
12,703.13
13,251.24
(0)
(0)
(0)
150.65
377.75
243.92
1113.35
918.33
1189.16
0.16
0.17
0.24
1,275.04
1,120.48
1,288.65
70.00
77.00
75.00
3.60
4.97
4.97
2,272
3,768
2,276
1,773.36
1449.87
0.24
1,230.08
50.00
#MACRO?
#MACRO?
#MACRO?
5.96
2,447
1,089.95
1300.83
0.26
941.25
40.00
#MACRO?
#MACRO?
#MACRO?
8.94
4,110
1,450.24
2487.91
0.25
824.16
40.00
#MACRO?
#MACRO?
#MACRO?
12.07
2,935
#MACRO?
#MACRO?
#MACRO?

6.36
3.30
2.46
#MACRO?
#MACRO?
2.71
#MACRO?
#MACRO?
1.73
#MACRO?
#MACRO?
3.15

0.15
0.10
235.09
188.78
1,587.52
1,830.19
#MACRO?
0.14
282.31
2,036.46
#MACRO?
#MACRO?
0.21
510.97
2,464.60
#MACRO?
#MACRO?
0.34
1,126.64
3,290.31
#MACRO?
54.10
9.03
54.17
8.95
54.17
8.88
36.87
36.88
36.95
54.10
54.17
54.17
45.90
45.83
45.83
0.28
0.32
0.29
#DIV/0! #MACRO? #MACRO?
685.50
1,100.65
0.56
0.30
0.57
54.17
11.19
34.64
54.17
45.83
#MACRO?
0.27
#MACRO?
1,100.28
#MACRO?
0.50
54.18
8.72
37.10
54.18
45.82
#MACRO?
0.28
#MACRO?
1,183.09
#MACRO?
0.23
54.19
6.30
39.54
54.19
45.84
#MACRO?
0.31
#MACRO?
4,051.83
#MACRO?
0.28
2010 (Annualized)
except the per share data)
15925.53
8871.52
7054.01
2921.61
4132.40
Average
390.63
4523.03
244.20
4278.83
207.08
4071.75
897.16
3174.59
#MACRO?
718.00
815.27
734.76
3220.23
3960.24
9448.50
9617.83
8029.25
8029.25
1588.57
5375.67
14993.49
24441.99
11,995.37
887.29
109.83
1405.73
2416.24
625.65
5444.75
1084.57
300.99
1385.56
2615.65
2713.95
10671.65
141.17
1469.25
17611.69
24442.00
(0)
2,398.46
3,005.45
0.22
1,458.86
#MACRO?
#MACRO?
#MACRO?
12.07
3,272.25
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2.87
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0.28
1,052.93
3,778.49
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0.28
#MACRO?
4,316.70
#MACRO?
0.45
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
1
2
4
5
6
7
8
9
10

Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
AVERAGE TOTAL ASSET

WEIGHT
PPE/TA
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
AMBEE
W.VALUE
0.22
0
0.13
0
2.61
0.02
20.32
0.14
#MACRO? #MACRO?
0
0
0
0
0
0
0
0.35
0
0.08
0
0.08
0
1.04
0.01
43.95
0.31
0.44
0
0.33
0
257.81
0.01
ACI
W.VALUE
#MACRO? #MACRO?
0.36
0.05
295.87
43.05
833.06
121.22
0.14
0.02
0
0
0
0
0
0
0
68.44
9.96
0.13
0.02
0.13
0.02
0.76
0.11
883.05
128.5
0.19
0.03
0.56
0.08
5,291.82
0.15
BEXIMCO
W.VALUE
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
14221.99
0.39
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0
0
0
0
0
0
0
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
GLAXO
W.VALUE
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
1,362.03
0.04
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0
0
0
0
0
0
0
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
IBN SINA
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
432.66
0.01
W.VALUE
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0
0
0
0
0
0
0
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
RENATA
W.VALUE
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
2,804.37
0.08
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0
0
0
0
0
0
0
0
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
SQUARE
W.VALUE
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
11,995.37
0.33
INDUSTRY. AVG
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0
0
0
0
0
0
0
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0.00
0.00
0.00
0.00
0.00
0.00
0.00
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
36,366.05
Compiled Data
Income Statement
Sales
Gross Profit
EBITDA
Depreciation
Other Income
EBIT
Interest Expense
WPPF
PBT
Income Tax
Deferred Tax
Profit After Tax
EPS
Balance Sheet
Current Assets
Inventories
Non-Current Assets
Fixed Asset
Net PP&E
Intangible Assets
Total Assets
Current Liabilities
Accounts Payables
Accrued Expenses
Other Payables
Share Premium
Retained Earnings
General Reserve
Other Reserve
Others
Revaluation Surplus
Check
Other Info
CapEx
Operating Cashflow
Effective Tax Rate
Dividend Per Share
Return On Equity
Retention Ratio

Debt Ratio
(STD+LTD)/TA
Debt-Equity Ratio

Tangibility
STDEV(EBIT)
Mean of EBIT
Growth Rate
Sponsors
Govt.
Foreign
Institutions
Public
Basic Earning Power
Stability Of Sales
LTD/E
EBIT/i
OCF/{i+(P/(1-T))}
PPE/TA
ROE*RR
S
F+I+P
EBIT/TA
EBIT/S
%ch.EBIT/%ch.S
STDEV(Sales)
BV/MV
2004
2005
13,071.15
7,763.57
5,307.58
2,452.32
2,855.26
487.03
267.61
2,635.85
440.45
2,195.39
93.77
2,101.62
344.75
12.69
1,744.18
#MACRO?
15,583.75
9,054.00
6,529.75
3,221.19
3,308.56
542.06
415.77
3,182.27
457.45
2,724.82
126.48
2,598.34
486.01
(46.06)
2,158.40
#MACRO?
2006
2007
2008
2009
17,712.78
21,473.06
24,611.21
30,575.23
10,105.83
12,340.09
14,110.07
17,015.79
7,606.95
9,132.97
10,501.14
13,559.44
3,903.05
4,679.82
5,463.53
6,702.73
3,703.89
4,453.15
5,037.61
6,856.71
582.04
854.05
711.60
1,319.31
295.85
415.78
1,468.37
1,594.32
3,417.71
4,014.88
5,794.39
7,131.72
535.02
690.64
965.81
1,017.09
2,882.68
3,324.24
4,828.58
6,114.63
138.29
155.73
184.08
240.27
2,744.39
3,168.51
4,644.50
5,874.36
585.80
696.39
934.27
1,061.06
39.43
63.75
79.07
269.47
2,119.16
2,408.38
3,631.16
4,543.83
#MACRO?
#MACRO?
#MACRO?
#MACRO?
433.07
815.89
1,534.30
3,873.75
835.83
7,492.83
1,073.70
1,041.74
2,038.51
4,572.28
1,301.95
10,028.18
1,093.06
1,109.78
1,873.51
5,215.46
1,917.37
11,209.18
434.29
1,470.66
2,983.19
5,584.21
1,439.14
11,911.49
721.91
1,453.31
3,326.87
7,405.71
2,370.34
15,278.14
2,636.94
1,840.42
4,360.76
7,599.37
3,213.41
19,650.90
10,559.07
11,653.69
1,567.70
10,085.99
473.08
1,573.94
5.06
12,138.07
12,344.56
13,449.49
1,945.35
11,504.14
840.42
2,101.22
0.09
14,445.87
14,011.17
15,171.80
2,319.49
12,852.31
1,158.87
2,415.82
31.10
16,458.10
15,910.17
17,831.40
2,924.39
14,907.01
1,003.17
3,410.70
18.86
19,339.74
20,237.84
22,329.28
3,419.44
18,909.84
1,328.00
4,377.05
17.42
24,632.32
22,192.99
25,679.71
4,329.80
21,349.91
843.08
5,673.95
19.86
5.73
27,892.53
19,630.90
24,474.05
27,667.28
31,251.22
39,910.46
47,543.43
555.55
177.09
668.05
3,130.78
368.49
4,899.94
601.24
396.39
1,031.93
3,566.71
1,230.13
6,826.39
712.20
433.75
1,328.40
4,231.80
990.29
7,696.44
707.21
503.80
2,002.12
4,817.62
644.81
8,675.56
1,170.30
522.54
1,974.91
7,866.07
1,143.44
12,677.26
1,333.29
724.40
2,478.45
6,335.86
688.48
11,560.48
2,406.58
391.91
2,798.49
2,094.68
429.04
2,523.72
1,995.29
582.50
2,577.80
2,633.21
671.75
3,304.95
2,398.52
827.58
3,226.10
2,740.70
5,349.42
8,090.12
1,367.72
3,775.24
4,753.84
110.88
724.59
968.38
231.80
11,932.44
1,850.32
3,775.24
6,147.56
110.88
1,001.67
2,008.43
229.79
15,123.88
2,010.27
3,775.24
7,553.78
110.88
979.28
2,734.34
229.23
17,393.01
2,229.83
3,775.24
9,040.37
110.88
1,027.95
2,791.58
294.92
19,270.75
2,661.67
3,775.24
12,061.72
110.88
591.68
2,791.58
2,014.30
24,007.05
3,287.82
3,775.24
15,189.64
110.88
627.32
2,984.26
1,917.66
27,892.81
19,630.88
24,473.99
27,667.24
31,251.27
39,910.42
47,543.41
(0)
723.73
1,679.72
0.17
130.80
157.75
#MACRO?
#MACRO?
#MACRO?
91.22
6,518.62
1,665.08
1,813.09
0.17
133.03
173.00
#MACRO?
#MACRO?
#MACRO?
113.68
7,351.79
1,723.78
2,525.90
0.23
126.34
160.50
#MACRO?
#MACRO?
#MACRO?
137.67
6,316.80
3,200.14
1,848.86
0.24
117.27
142.00
#MACRO?
#MACRO?
#MACRO?
164.33
9,961.38
5,142.81
1,703.08
0.22
124.67
119.50
#MACRO?
#MACRO?
#MACRO?
192.57
14,041.55
3,726.28
4,888.12
0.23
125.23
137.00
#MACRO?
#MACRO?
#MACRO?
222.73
18,073.11
2004
2005
2006
2007
2008
2009
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
1.90
#MACRO?
#MACRO?
0.94
#MACRO?
#MACRO?
1.39
#MACRO?
#MACRO?
1.20
#MACRO?
#MACRO?
0.70
#MACRO?
#MACRO?
2.56
#MACRO?
#MACRO?
0.13
401.11
3,078.61
#MACRO?
#MACRO?
0.12
429.20
3,538.29
#MACRO?
#MACRO?
0.28
1,236.38
4,408.99
#MACRO?
#MACRO?
0.28
1,563.64
5,647.00
#MACRO?
#MACRO?
0.26
1,991.68
7,546.21
#MACRO?
#MACRO?
0.20
#MACRO?
2,323.45
#MACRO?
0.02
#MACRO?
0.19
#MACRO?
2,982.07
#MACRO?
0.02
#MACRO?
0.19
#MACRO?
3,453.89
#MACRO?
0.01
#MACRO?
0.24
#MACRO?
4,623.62
#MACRO?
0.01
#MACRO?
0.23
#MACRO?
8,436.27
#MACRO?
0.01
#MACRO?
#MACRO?
0.20
#DIV/0!
#MACRO?
0.02
2010
the per share data)
41,261.98
22,791.46
18470.52
9,017.14
9453.38
714.54
973.68
9712.52
1,181.04
8531.48
385.30
8146.18
1,583.26
285.54
6277.38
#MACRO?
3,301.11
2,509.88
5,823.66
9,425.55
4,819.64
25879.85
31083.85
28,773.86
321.45
28452.41
2,631.44
7,045.85
22.03
53.46
38205.18
64085.03
Average
2,259.09
857.42
2,808.88
7,910.80
1,289.05
15125.24
4,180.01
1,752.90
5932.91
5,336.98
8,233.44
22,614.67
146.17
2,149.85
2,114.51
2,431.18
43026.81
64084.96
0
6,674.71
6,984.96
0.23
170.31
105.00
#MACRO?
#MACRO?
#MACRO?
252.64
19,962.27
2010
Average
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2.45
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0.22
1,824.90
8,422.12
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
0.24
#MACRO?
7,556.67
#MACRO?
0.01
#MACRO?
#MACRO?
#MACRO?
#DIV/0!
#MACRO?
#MACRO?
#MACRO?
Simple & Weighted Average

Total Asset
ACI
AMBEE
BEXIMCO
GLAXO
IBN SINA
RENATA
SQUARE
Industry
Relative Weight (based on Total Asset)

ACI
AMBEE
BEXIMCO
GLAXO
IBN SINA
RENATA
SQUARE
Industry
Tangibility
ACI
AMBEE
BEXIMCO
GLAXO
IBN SINA
RENATA
SQUARE
Simple Average
Weighted Average

ACI
AMBEE
BEXIMCO
GLAXO
IBN SINA
RENATA
2004
2,378.68
181.33
8,658.47
1,103.83
260.30
1,170.93
5,877.36
19,630.90
2005
2,674.66
207.20
10,945.53
1,072.83
290.71
1,375.19
7,907.93
24,474.05
12%
1%
44%
6%
1%
6%
30%
100%
11%
1%
45%
4%
1%
6%
32%
100%
2004
#MACRO?
0.27
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2005
#MACRO?
0.23
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2004
-
2005
0.16
0.21
0.18
1.14
0.22
0.33
SQUARE
Simple Average
Weighted Average
0.15
0.34
0.22
2006
2,915.15
274.97
11,912.50
1,010.96
336.22
1,918.49
9,298.99
27,667.28
2007
4,730.78
287.29
11,953.42
1,068.47
397.99
2,326.34
10,486.94
31,251.22
2008
6,915.05
278.58
14,819.67
1,362.35
513.66
3,318.03
12,703.13
39,910.46
2009
7,742.20
288.94
19,891.92
1,701.50
604.09
4,063.53
13,251.24
47,543.43
2010
9,686.22
286.39
21,372.41
2,214.29
625.62
5,458.11
24,441.99
64,085.03
11%
1%
43%
4%
1%
7%
34%
100%
15%
1%
38%
3%
1%
7%
34%
100%
17%
1%
37%
3%
1%
8%
32%
100%
16%
1%
42%
4%
1%
9%
28%
100%
15%
0%
33%
3%
1%
9%
38%
100%
2006
#MACRO?
0.21
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2007
#MACRO?
0.21
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2008
#MACRO?
0.21
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2009
#MACRO?
0.20
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2010
#MACRO?
0.20
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
#MACRO?
2006
0.43
0.24
0.09
0.95
0.21
0.24
2007
0.75
0.13
0.20
1.14
0.35
0.21
2008
0.43
0.13
0.28
0.74
0.25
0.29
2009
0.19
0.07
0.41
0.43
0.23
0.33
2010
0.22
0.01
0.38
0.16
0.22
0.24
Average
5,291.82
257.81
14,221.99
1,362.03
432.66
2,804.37
11,995.37
36,366.05
15%
1%
39%
4%
1%
8%
33%
100%
0.10
0.32
0.17
0.14
0.42
0.30
0.21
0.33
0.30
0.34
0.29
0.34
0.28
0.22
0.29
Tangibility
ACI
2004
2005
2006
2007
2008
2009
2010
AMBEE
BEXIMCO GLAXO
IBN SINA RENATA SQUARE
0.29
0.27
0.71
0.25
0.56
0.47
0.38
0.28
0.23
0.68
0.27
0.55
0.39
0.29
0.24
0.21
0.71
0.3
0.55
0.43
0.24
0.18
0.21
0.75
0.3
0.55
0.4
0.34
0.16
0.21
0.8
0.24
0.5
0.34
0.32
0.15
0.2
0.65
0.21
0.55
0.39
0.37
0.18
0.2
0.71
0.17
0.53
0.51
0.33

ACI
AMBEE
BEXIMCO GLAXO
IBN SINA RENATA SQUARE
2004
2005
0.16
0.21
0.18
1.14
0.22
0.33
0.15
2006
0.43
0.24
0.09
0.95
0.21
0.24
0.1
2007
0.75
0.13
0.2
1.14
0.35
0.21
0.14
2008
0.43
0.13
0.28
0.74
0.25
0.29
0.21
2009
0.19
0.07
0.41
0.43
0.23
0.33
0.34
2010
0.22
0.01
0.38
0.16
0.22
0.24
0.28
1
2
3
4
25th percentile 50th percentile 75th percentile Maximum value
2004
2005
2006
2007
2008
2009
2010
2004
2005
2006
2007
2008
2009
2010
Q1
0.28
0.27
0.24
0.25
0.23
0.2
0.19
Q2
0.38
0.29
0.3
0.34
0.32
0.37
0.33
Q3
0.51
0.47
0.49
0.47
0.42
0.47
0.52
Q4
0.71
0.68
0.71
0.75
0.8
0.65
0.71
Q1
Q2
Q3
Q4
0.17
0.16
0.17
0.23
0.21
0.19
0.21
0.24
0.21
0.28
0.33
0.22
0.27
0.33
0.55
0.36
0.37
0.26
1.14
0.95
1.14
0.74
0.43
0.38
Industry Simple
0.51
0.47
0.46
0.48
0.47
0.45
0.44
Avg Weighted Avg

0.42
0.51
0.38
0.47
0.38
0.46
0.39
0.48
0.37
0.47
0.36
0.45
0.37
0.44
Industry Simple Avg Weighted Avg

0.13
0.12
0.28
0.28
0.26
0.22
0.34
0.32
0.42
0.33
0.29
0.22
0.22
0.17
0.3
0.3
0.34
0.29
Average of Tangibility
Commpany Name
ACI
Ambee
Beximco
Glaxo
Ibn Sina
Renata
Square
Grand Total
Year
2004
0.29
0.27
0.71
0.25
0.56
0.47
0.38
0.42
2005
0.28
0.23
0.68
0.27
0.55
0.39
0.29
0.38
2006
0.24
0.21
0.71
0.3
0.55
0.43
0.24
0.38
2007
0.18
0.21
0.75
0.3
0.55
0.4
0.34
0.39
2008
0.16
0.21
0.8
0.24
0.5
0.34
0.32
0.37
2009
0.15
0.2
0.65
0.21
0.55
0.39
0.37
0.36
2010 Grand Total

0.18
0.21
0.2
0.22
0.71
0.72
0.17
0.25
0.53
0.54
0.51
0.42
0.33
0.33
0.37
0.38
Commpany
Name
ACI
ACI
ACI
ACI
ACI
ACI
ACI
Ambee
Ambee
Ambee
Ambee
Ambee
Ambee
Ambee
Beximco
Beximco
Beximco
Beximco
Beximco
Beximco
Beximco
Glaxo
Glaxo
Glaxo
Glaxo
Glaxo
Glaxo
Glaxo
Ibn Sina
Ibn Sina
Ibn Sina
Ibn Sina
Ibn Sina
Ibn Sina
Ibn Sina
Renata
Renata
Renata
Renata
Renata
Renata
Renata
Year
2004
2005
2006
2007
2008
2009
2010
2004
2005
2006
2007
2008
2009
2010
2004
2005
2006
2007
2008
2009
2010
2004
2005
2006
2007
2008
2009
2010
2004
2005
2006
2007
2008
2009
2010
2004
2005
2006
2007
2008
2009
2010
Tangibility
0.29
0.28
0.24
0.18
0.16
0.15
0.18
0.27
0.23
0.21
0.21
0.21
0.2
0.2
0.71
0.68
0.71
0.75
0.8
0.65
0.71
0.25
0.27
0.3
0.3
0.24
0.21
0.17
0.56
0.55
0.55
0.55
0.5
0.55
0.53
0.47
0.39
0.43
0.4
0.34
0.39
0.51
Uncertainty Of
Operating
Income
0.16
0.43
0.75
0.43
0.19
0.22
0.21
0.24
0.13
0.13
0.07
0.01
0.18
0.09
0.2
0.28
0.41
0.38
1.14
0.95
1.14
0.74
0.43
0.16
0.22
0.21
0.35
0.25
0.23
0.22
0.33
0.24
0.21
0.29
0.33
0.24
Growth Rate
0.02
0.04
0.06
0.14
0.4
0.24
0.08
0.02
-0.03
0
0.04
0.01
0.02
0.03
0.01
-0.1
0
-0.03
0.04
0.06
0.07
0.15
0.02
-0.04
0.02
0.08
0.11
0.12
0.07
0.09
0.01
0.04
0.19
0.19
0.18
0.18
0.23
0.26
0.21
0.2
0.23
0.26
Square
Square
Square
Square
Square
Square
Square
2004
2005
2006
2007
2008
2009
2010
0.38
0.29
0.24
0.34
0.32
0.37
0.33
0.15
0.1
0.14
0.21
0.34
0.28
0.16
0.16
0.12
0.14
0.12
0.14
0.18
Basic Earning
Power
0.1
0.1
0.11
0.12
0.21
0.17
0.1
0.09
0.07
0.08
0.08
0.07
0.07
0.07
0.06
0.07
0.07
0.06
0.07
0.06
0.1
0.19
0.07
0
0.08
0.16
0.26
0.25
0.16
0.16
0.09
0.1
0.12
0.11
0.15
0.21
0.26
0.26
0.25
0.22
0.25
0.26
Operating Profit
Margin
0.09
0.08
0.09
0.12
0.24
0.19
0.12
0.09
0.09
0.1
0.07
0.08
0.08
0.08
0.23
0.22
0.22
0.19
0.25
0.25
0.32
0.16
0.06
0
0.05
0.11
0.15
0.15
0.1
0.09
0.05
0.05
0.06
0.05
0.06
0.17
0.2
0.23
0.21
0.23
0.25
0.27
Degree of
Operating
Leverage
Stability Of Sales
0.41
1.72
1.65
4.53
-0.41
-3.37
479.98
956.58
1225.91
1157.36
992.61
485.87
1.03
1.78
0.12
0.73
2.33
0.22
24.33
89.53
67.44
58.1
13.89
10.41
0.82
0.87
6.02
3.58
0.94
1.9
668.86
193.58
214.69
648.46
1259.82
1147.35
-16.87
-32.7
22.86
5.18
1.5
1.25
83.73
124.17
228.48
756.85
885.17
430.22
0.61
-5.63
0.93
1.41
0.6
1.37
65.98
137.69
237.82
243.31
277.99
231.44
1.8
1.69
0.68
1.54
1.33
1.22
348.25
475.46
519.47
697.27
1117.3
934.69
0.22
0.21
0.19
0.2
0.18
0.23
0.19
0.28
0.32
0.29
0.27
0.28
0.31
0.28
2.06
0.24
0.75
1.28
1.56
-0.2
685.5
1100.65
1100.28
1183.09
4051.83
4316.7
Operating
Expense Ratio
0.19
0.23
0.24
0.22
0.08
0.14
0.23
0.4
0.4
0.44
0.37
0.51
0.48
0.47
0.23
0.28
0.29
0.3
0.28
0.28
0.23
0.11
0.19
0.22
0.18
0.16
0.18
0.2
0.26
0.28
0.33
0.33
0.34
0.34
0.34
0.3
0.28
0.28
0.27
0.28
0.29
0.28
BV-MV Ratio
(Proxy For
Distress)
0.56
0.81
0.87
0.43
0.26
0.37
0.61
0.42
0.55
0.52
0.45
0.18
0.11
0.05
1.01
2.03
1.47
1.22
0.41
0.4
0.59
0.49
0.5
0.47
0.34
0.23
0.13
0.1
0.21
0.3
0.28
0.24
0.21
0.13
0.15
0.35
0.44
0.43
0.19
0.16
0.11
0.11
0.18
0.14
0.18
0.2
0.17
0.18
0.16
0.56
0.3
0.57
0.5
0.23
0.28
0.45

Capital Structure Analysis - Bangladesh (Rezwana Nasreen & M. Shahryar Faiz)

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Capital Structure Analysis - Bangladesh (Rezwana Nasreen & M. Shahryar Faiz)

Uploaded by

Copyright:

Available Formats

ACI Pharmaceuticals Limited

Time Series Analysis

Determinants Of Capital Structure

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

Ambee Pharmaceuticals Ltd

Time Series Analysis

Interest Coverage Ratio

Determinants Of Capital Structure

Time Series Analysis

Determinants Of Capital Structure

Glaxo Smithkline Bangladesh Limited

Time Series Analysis

Determinants Of Capital Structure

eferred tax liability)

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO?

IBN SINA Pharmaceuticals IND LTD

Total Liabilities & Shareholders' Equity

Time Series Analysis

Interest Coverage Ratio

Determinants Of Capital Structure

### #MACRO? #MACRO? #MACRO?

### #MACRO? #MACRO? #MACRO?

### #MACRO? #MACRO? #MACRO?

Time Series Analysis

Determinants Of Capital Structure

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO? #MACRO? #MACRO?

Time Series Analysis

Determinants Of Capital Structure

#MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO?

#MACRO? #MACRO? #MACRO?

Determinants Of Capital Structure

AVERAGE TOTAL ASSET

Time Series Analysis

Determinants Of Capital Structure

Simple & Weighted Average

Relative Weight (based on Total Asset)

Uncertainty Of Operating Income

Uncertainty Of Operating Income

Avg Weighted Avg

Industry Simple Avg Weighted Avg

2010 Grand Total

You might also like